Dexcom Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Go back to Dexcom Reports Fourth Quarter and Fiscal Year 2018 Financial Results

DexCom (DXCM) PT Raised to $175 at Cowen Following 4Q Report

February 22, 2019 6:43 AM EST

Cowen analyst Doug Schenkel raised the price target on DexCom (NASDAQ: DXCM) to $175.00 (from $150.00) while maintaining a Outperform rating following the company's 4Q. Revenue of $338MM came in $53MM ahead of original consensus expectations and $7MM higher than pre-announced results. Gross margin of... More

DexCom (DXCM) Tops Q4 EPS by 37c

February 21, 2019 4:38 PM EST

DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.54, $0.37 better than the analyst estimate of $0.17. Revenue for the quarter came in at $338 million versus the consensus estimate of $307.52 million.

GUIDANCE:

DexCom sees FY2019 revenue of $1.175-1.225 billion, versus the consensus of $1.28... More